Page 1584 - Small Animal Internal Medicine, 6th Edition

1556 Index

Drugs (Continued) Echocardiography (Continued) Ehrlichiosis (Continued) Electrolytes
for joint diseases, 1209t–1210t infective endocarditis, 136, 136f hypoalbuminemia and, 1475 fractional clearance of, 664
in Greyhounds, 1362, 1362t
for metabolic disorders, 934t pressure gradient estimation, 30–31 prevention of, 1477 Electromyography, 1071–1072,
VetBooks.ir obesity and, 901 heartworm disease findings chronic, 1474–1475 Electron microscopy, 415, 1433
for neurologic disorders, 1185t–1186t
pulsed wave, 28–30, 29f–30f
treatment of, 1476–1477
tissue imaging, 32, 32f
zoonotic aspects of, 1477
1174–1175
for reproductive disorders,
1034t–1036t
in dogs, 197, 197f
feline monocytotropic, 1477–1478
Electroretinography, 1072
for respiratory disorders, 386t–388t in cats, 206 description of, 1118t Electrophoretograms, 1421, 1421f
therapy, in pediatric dogs and cats, hypertension findings, 213–214 Eicosapentaenoic acid, 72–73 Elemental diets, 437
1013 hypertrophic cardiomyopathy findings Eisenmenger syndrome, 114 Elimination diets, 434
thrombocytopenia caused by, 1395 in cats, 160–162, 163f–164f Ejaculation, obstructive disorders of, ELISA. see Enzyme-linked
tremors induced by, 1183 infective endocarditis, 136, 136f 1004–1005 immunosorbent assay
for urinary tract disorders, 737t–739t mitral dysplasia findings, 112 Ejection murmurs, 9–10 Elliptocytosis, 1345t, 1386
Ductal plate abnormalities, in cats, mitral regurgitation findings, Elbow, arthrocentesis method in, 1191f Elokomin fluke fever, 480
574–575 125f–126f, 144f Electrical alternans, 46, 181f Emesis, 1100b
Dulcolax. see Bisacodyl M-mode, 22–27 Electrocardiography, 34–51 Emphysema, 330b
Dwarfism, pituitary, 753–757 atrial fibrillation on, 81f accelerated idioventricular rhythm, 41 Enalapril, 64t, 68, 217t, 1255t–1256t
in cats, 786f dilated cardiomyopathy on, 144f ambulatory, 49–51 Enalaprilat, 217t
clinical features of, 754 measurements on, 23–27 Holter monitoring, 49–50 Encephalitis, 1080, 1117, 1129
clinical pathology of, 754 mitral valve motion, 26, 27f intermittent event recording, 50–51 Encephalomyelitis, 1122–1123, 1520
clinical signs of, 754, 754b, 755f normal values for, 23–27, 25t artifacts, 48, 51f Endocardial fibroelastosis, 100, 117
diagnosis of, 754–755, 756f, 756b patent ductus arteriosus findings, atrial fibrillation, 40, 43f Endocarditis
endocrine alopecia caused by, 748t 103–104, 105f atrial flutter, 39 bacterial, 1440–1442
etiology of, 753–754 pericardial effusion findings, bundle branch block patterns, 45–46 infective
growth hormone therapy for, 755–757 179–180, 179f cardiac tumors on, 187 antibiotics for, 136–137
lanugo retention associated with, 754 views on, 23, 24f in cats, 38t antimicrobial prophylaxis for, 138
prognosis for, 757 pericardiocentesis monitoring using, chamber enlargement, 45–46, 46f, bacteremia, 132
signalment, 754 183 46b–47b blood culture testing for, 133–134
treatment of, 755–757 principles of, 19–20 conduction disturbances, 42–45 in cats, 132
Dynamin-associated exercise-induced pulmonary hypertension findings, 192, dilated cardiomyopathy findings, cephalosporins for, 136–137
collapse (dEIC), 1106–1107, 1107f, 192f 142–144 clinical features of, 133
1183–1184 with shunt reversal, 115–116 in dogs, 35t congestive heart failure secondary
Dysautonomia, 456, 1172–1173 pulmonic stenosis findings, 108, 110f drug toxicities, 47–48, 49b to, 132
Dyskinesias, 1181, 1183 restraints for, 19–20 ectopic rhythms, 38–42, 41f–42f diagnosis of, 133–136, 135b
Dysphagia, 389–391 subaortic stenosis, 106–107, 106f electrolyte imbalance, 47–48, 49b in dogs, 132
causes of, 390b tetralogy of Fallot findings, 114 escape complexes, 41–42 Doppler imaging of, 136, 136f
cricopharyngeal achalasia/dysfunction, three-dimensional, 33 heart rate variability, 48 echocardiography of, 133–134,
451–452 transesophageal, 32–33, 33f heart rhythm, 37 136f
halitosis and, 389–391 tricuspid dysplasia findings, 112–113, heartworm disease etiology of, 132–133
masticatory muscle myositis, 451 113f in cats, 206–207 immune-mediated disease versus,
neurogenic, 391 two-dimensional, 20–22 in dogs, 197 133
pharyngeal, 452 long-axis views, 21f, 23f hyperkalemia, 690–691, 919–920, 920b laboratory tests for, 134
in pharyngeal diseases, 271–272 in parasternal position, 20f–23f hypertrophic cardiomyopathy findings, microorganisms associated with,
regurgitation and, 391–392 short-axis views, 20f, 22f 160–163, 162f 132
Dyspnea speckle tracking, 32 interpretation of, 35–37, 78b neutrophilia associated with, 134
in cats, 4, 4f views on, 20–22 lead systems, 35, 36f, 36b nonregenerative anemia associated
in dogs, 4, 4f ventricular septal defect findings, mean electrical axis, 45 with, 134
Dystocia, 969, 1034t–1036t 110–111, 110f normal waveforms, 26t, 34–35, 35f pathophysiology of, 132–133
causes of, 969 Echogenicity, 19 pericardial effusion findings, 181–183 prognosis for, 136–138
cesarean section for, 972–974, 974f Eclampsia, 975–976 pulmonary hypertension findings, 192 prophylactic antibiotics for, 138
definition of, 969 Ectopic rhythms QRS abnormalities, 46 sequelae of, 134b
fetal anomalies as cause of, 969, electrocardiography of, 38–42, 41f–42f QT interval, 47 signs of, 133
970f–971f supraventricular premature complexes, sick sinus syndrome, 86 systemic effects of, 134b
fetal factors associated with, 969 39 sinus arrhythmia, 40f thromboemboli caused by, 133
flowchart for, 970f supraventricular tachycardias, 39 sinus bradycardia, 40f treatment of, 136–138
medical therapy for, 969–972 Ectopic ureters, 730–732, 731f, 1026 sinus rhythms, 37, 40f valves commonly affected by, 132
obstructive, 971f Edema ST-T abnormalities, 46–47, 48b vegetations associated with, 132
Dysuria, 652–653, 653b pregnancy, 967, 968f supraventricular premature complexes, Endocrine alopecia, 747–749, 747f,
pulmonary. see Pulmonary edema 39 748t–749t, 750f
E scrotal, 1001f supraventricular tachycardias, 39 Endocrine replacement therapy, chronic
Ebstein anomaly, 112–113 Edrophonium chloride, 1170–1171 ventricular fibrillation, 41, 43f kidney disease, 701–702
Ecchymotic hemorrhages, 1242f adverse effects of, 98 ventricular premature complexes, 40 Endometrial hyperplasia, 956f
Echinococcus granulosa, 1533t–1535t, in cats, 90t–91t ventricular septal defect findings, 110 Endometritis, postpartum, 977–978,
1537 in dogs, 90t–91t ventricular tachycardia, 41 977f
Echinococcus multilocularis, 1533t–1535t, dosage of, 90t–91t Wolff-Parkinson-White preexcitation, Endomyocardial biopsy, 52
1537 neurologic disorders treated with, 44–45 Endoscopy, 436
Echinocytosis, 1345t 1185t–1186t Electroencephalography, 1072 alimentary tract disease evaluations,
Echocardiography, 18 Effusion Electrolyte imbalances, 915–933 424–429, 425f
arterial thromboembolism abdominal, 519 electrocardiographic changes biopsy use of, 426
in cats, 225 feline infectious peritonitis, 1490, associated with, 47–48, 49b capsule, 429
in dogs, 231 1490f hypercalcemia, 48, 49b, 761t, 923–927, flexible, 424
atrial septal defect findings, 111 pericardial. see Pericardial effusion 1268, 1298 hematemesis evaluation, 399–401
atrioventricular valve disease findings, pleural. see Pleural effusion hyperkalemia, 47–48, 49b, 50f, removal of foreign objects, 467
123–126, 124f Ehrlichia spp., 1533t–1535t 690–691, 919–921, 920b, 921t rigid, 424, 426
cardiac tamponade findings, 180f E. canis, 1241–1242, 1432–1433, 1440t, hypermagnesemia, 933 Endothelin, physiologic effects of, 58
cardiac tumors on, 187, 187f 1470t, 1473, 1475f, 1477 hypernatremia, 915–917, 916b, 917t Endotracheal technique, for tracheal
in cats, 26t E. chaffeensis, 1470t, 1473, 1477 hyperphosphatemia, 691, 929–930, wash, 300–303
constrictive pericardial disease E. ewingii, 1440t, 1470t, 1478 929b Endotracheal tubes, 384
findings, 185 Ehrlichiosis hypocalcemia, 48, 49b, 765t, 927–929, End-systolic volume index (ESVI), 26,
contrast, 27, 28f canine granulocytotropic, 1478–1479 928b 120
dilated cardiomyopathy findings, 144f, canine monocytotropic, 1473–1477 hypokalemia, 47, 49b, 921–923, 922b, Enema, 443–446
170 clinical features of, 1474, 1474t 923t barium contrast, 423
in dogs, 26t diagnosis of, 1474–1476, 1475f, hypomagnesemia, 844, 931–933, 932b cleansing, 445
Doppler, 27–32 1475t hyponatremia, 74, 917–919, 918b hypertonic, 445
color flow mapping, 31–32, 31f–32f epidemiology of, 1473–1474 hypophosphatemia, 843–844, 930–931, retention, 445
continuous wave, 30, 31f etiology of, 1473–1474 930b Enilconazole, 261